Minimal impact

Mixed findings for benefits of tamper-resistant oxycodone The introduction of tamper-resistant oxycodone formulations in Australia in early 2014 has led to little change in the levels of population-level opioid use or harm, new research has revealed. Time-series analyses of opioid sales data and collected health datasets have shown that controlled-release oxycodone reduced tampering with pharmaceutical